Biggest News Aggregation in the World
๐Ÿ“ฐ Controller General News

Page 128 - Controller General News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Controller General. Real-time updates on events, politics, business and more.

FinMin restores expenditure norm for Central ministries and depts

Ministries allowed to spend 33% of BE in January-March quarter January 06, 2021 The key Ministries and Departments include commerce, telecom, coal, environment, mines and MSMEs. ย  - ย istock.comร— FinMin, however, says that the spending should remain within the revised estimate The Finance Ministry has restored quarterly and monthly expenditure limit as prescribed in 2017 for the last three months โ€” January-March of FY20-21. This means higher expenditure by various Central Ministries and Dep...
Union Territories Finance Ministry Central Ministries Revised Estimate Central Government Ministries Controller General

"Why Stage-3 Trials Given A Miss?" Congress Leaders Ask Of Covid Vaccine Approval

Stage-3 Trials Given A Miss: Congress Leaders On Covid Vaccine Approval Stage-3 Trials Given A Miss: Congress Leaders On Covid Vaccine Approval Congress leader Salman Nizami went to the extent of tweeting: "Vaccine is a fraud." Updated: January 03, 2021 5:41 pm IST A parliamentary panel had earlier recommended proper conduct of vaccine trials. New Delhi: The Indian government must explain why mandatory protocols and verification of data from stage-3 trials have been dispensed with while gr...
Salman Nizami Shashi Tharoor Jairam Ramesh Akhilesh Yadav Randeep Guleria Hardeep Singh Puri
Source: ndtv.com

Bharat Biotech Oxford Covaxin Covishield Serum Institute DCGI final approval coronavirus vaccine emergency use

URL copied Covishield, Covaxin get govts nod Drug Controller General of India (DCGI) on Sunday approved Serum Institute of Indias Covishield vaccine and Bharat Biotechs Covaxin for emergency use against coronavirus. The development, eleven months after the first case of deadly coronavirus was detected in India, has paved the way for their roll-out and administration to millions. The vaccine will be first offered to one crore healthcare workers, along with two crore frontline and essen...
United Kingdom Oxford Astrazeneca Covishield Astrazeneca Oxford University Serum Institute Of India Covishield National Institute Of Virology Indian Council Of Medical Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

The Latest: In big step, India approves 2 COVID-19 vaccines | Taiwan News

2021/01/03 16:35 Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca are checked as they arrive at the Princess Royal Hos... Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca are checked as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday Jan. 2, 2021. The UK has 530,000 doses available for rollout from Monday. (Gareth Fuller/Pool via AP) ...
North Carolina United States New York United Kingdom Australian Capital Territory New Delhi

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science